Antibiotics disrupt protective gut mucus and heighten IBD risk

In a landmark study published today in Science Advances, Dr. Shai Bel and his research team at the Azrieli Faculty of Medicine of Bar-Ilan University have uncovered crucial insights into how antibiotic use increases the risk of inflammatory bowel disease (IBD).

Numinus Announces Psychedelic Program for Mental Distress Associated with Chronic and Serious Illness through Cedar Clinical Research – Psychedelic Alpha

VANCOUVER, BC, Oct. 3, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) – a mental health care company advancing innovative

October 3, 2023

Mahvash Disease Case Resolved With Liver Transplantation

A woman with Mahvash disease presented with portal hypertension that necessitated liver transplantation; the liver complications observed in this case report distinguish it from what’s

November 23, 2023

Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Candidate – Psychedelic Alpha

This preliminary data provides an early look at how deuterated psychedelics perform in the clinic compared to their non-deuterated counterparts. Besides offering a potentially clearer

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.